Omega Therapeutics is delveoping an approach to use mRNA therapeutics as programmable epigenetic medicines by utilizing its OMEGA Epigenomic Programming platform. Co. designs and engineers its mRNA therapeutics, which are programmable and modular epigenetic medicines, called Omega Epigenomic Controllers (OECs) to target EpiZips for Precision Genomic Control. Co.'s pipeline consists of early-stage, preclinical programs that span oncology, multigenic diseases. Co. has conducted in vivo preclinical studies of its OECs in multiple disease models for various indications, including hepatocellular carcinoma, non-small cell lung cancer, and acute respiratory distress syndrome. We show 10 historical shares outstanding datapoints in our OMGA shares outstanding history coverage, used to compute OMGA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OMGA market cap history over the course of time is important for investors
interested in comparing OMGA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OMGA versus a peer is one thing; comparing
OMGA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OMGA can fluctuate over the course of history.
With this page we aim to empower investors researching OMGA by allowing them to research the OMGA market cap history. |
Free OMGA Email Alerts:
Video: The Importance of Market Cap
